Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations

European Journal of Pharmaceutical Sciences

Volumn 19, Issue 4, 2003, Pages 299-304

  Odeberg, Johanna Mercke ^a   Lignell, Åke ^b   Pettersson, Annette ^b   Höglund, Peter ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b AstaCarotene AB   (Sweden)

Author keywords

Astaxanthin; Bioavailability; Lipid based formulations; Pharmacokinetics; Polysorbate 80

Indexed keywords

ABSORPTION; ALGAE; ANTIOXIDANTS; FOOD PRODUCTS; GLYCEROL; HYDROCARBONS; LIPIDS; OILS AND FATS; PHARMACOKINETICS; SURFACE ACTIVE AGENTS; SYNTHESIS (CHEMICAL);

BIOAVAILABILITY;

DRUG PRODUCTS;

ANTIOXIDANT; ASTAXANTHIN; GLYCEROL DIOLEATE; GLYCEROL OLEATE; LONG CHAIN TRIACYLGLYCEROL; PALM OIL; POLYSORBATE 80; SORBITAN OLEATE; SURFACTANT;

ADULT; ARTICLE; BLOOD SAMPLING; CALCULATION; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; HEADACHE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; MALE; MEAL; NORMAL HUMAN; OPEN STUDY; PARALLEL DESIGN; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; VOLUNTEER;

EID: 0042168660     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(03)00135-0     Document Type: Article

References (20)

1. Borel P., Tyssandier V., Mekki N., Grolier P., Rochette Y., Alexandre-Gouabau M.C., Lairon D., Azais-Braesco V. Chylomicron beta-carotene and retinyl palmitate responses are dramatically diminished when men ingest beta-carotene with medium-chain rather than long-chain triglycerides. J. Nutr. 128:1998;1361-1367.
2. Caliph S.M., Charman W.N., Porter C.J. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci. 89:2000;1073-1084.
3. Charman W.N., Porter C.J., Mithani S., Dressman J.B. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci. 86:1997;269-282.
4. Clark R.M., Yao L., She L., Furr H.C. A comparison of lycopene and astaxanthin absorption from corn oil and olive oil emulsions. Lipids. 35:2000;803-806.
5. Erdman J.W. Jr., Deming D.M. Mammalian carotenoid absorption and metabolism. Pure Appl. Chem. 71:1999;2213-2223.
6. Gershanik T., Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 50:2000;179-188.
7. Gibaldi M., Perrier D. Pharmacokinetics. 1982;Marcel Dekker, New York.
8. Humberstone A.J., Charman W.N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 25:1997;103-128.
9. Iwamoto T., Hosoda K., Hirano R., Kurata H., Matsumoto A., Miki W., Kamiyama M., Itakura H., Yamamoto S., Kondo K. Inhibition of low-density lipoprotein oxidation by astaxanthin. J. Atheroscler. Thromb. 7:2000;216-222.
10. Kurashige M., Okimasu E., Inoue M., Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol. Chem. Phys. Med. NMR. 22:1990;27-38.
11. Olson J.A. Absorption, transport, and metabolism of carotenoids in humans. Pure Appl. Chem. 66:1994;1011-1116.
12. Olson J.A. Carotenoids. Shils M.E., Olson J.A., Shike M., Ross A.C. Modern Nutrition in Health and Disease. 1999;Lippincott Williams and Wilkins, Pennsylvania, PA.
13. Osterlie M., Bjerkeng B., Liaaen-Jensen S. Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J. Nutr. Biochem. 11:2000;482-492.
14. Paiva S.A., Russell R.M. Beta-carotene and other carotenoids as antioxidants. J. Am. Coll. Nutr. 18:1999;426-433.
15. Parker R.S. Absorption, metabolism, and transport of carotenoids. FASEB J. 10:1996;542-551.
16. Porter C.J., Charman W.N. In vitro assessment of oral lipid based formulations. Adv. Drug Deliv. Rev. 50:(Suppl. 1):2001;S127-S147.
17. Porter C.J., Charman W.N. Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 50:2001;61-80.
18. Pouton C.W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. 11:2000;S93-S98.
19. Rock C.L. Carotenoids: biology and treatment. Pharmacol. Ther. 75:1997;185-197.
20. Zaripheh S.E.J.W. Factors that influence the bioavailability of xanthophylls. J. Nutr. 132:2002;531S-534S.